These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 14500389)
1. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389 [TBL] [Abstract][Full Text] [Related]
2. [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging]. Yu ZQ; Zhou JH; Tao KT; Hu L; Zheng J; Yang DT Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1092-5. PubMed ID: 19781277 [TBL] [Abstract][Full Text] [Related]
3. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein. Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802 [TBL] [Abstract][Full Text] [Related]
4. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Bouvet M; Wang J; Nardin SR; Nassirpour R; Yang M; Baranov E; Jiang P; Moossa AR; Hoffman RM Cancer Res; 2002 Mar; 62(5):1534-40. PubMed ID: 11888932 [TBL] [Abstract][Full Text] [Related]
5. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Hoffman RM Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987 [TBL] [Abstract][Full Text] [Related]
6. Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice. Tsuji K; Yang M; Jiang P; Maitra A; Kaushal S; Yamauchi K; Katz MH; Moossa AR; Hoffman RM; Bouvet M JOP; 2006 Mar; 7(2):193-9. PubMed ID: 16525203 [TBL] [Abstract][Full Text] [Related]
7. Lentivirus-based DsRed-2-transfected pancreatic cancer cells for deep in vivo imaging of metastatic disease. Zhou J; Yu Z; Zhao S; Hu L; Zheng J; Yang D; Bouvet M; Hoffman RM J Surg Res; 2009 Nov; 157(1):63-70. PubMed ID: 19589544 [TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models. Bouvet M; Hoffman RM Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403 [TBL] [Abstract][Full Text] [Related]
9. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M Clin Exp Metastasis; 2004; 21(1):7-12. PubMed ID: 15065597 [TBL] [Abstract][Full Text] [Related]
10. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825 [TBL] [Abstract][Full Text] [Related]
11. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer. Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024 [TBL] [Abstract][Full Text] [Related]
12. Antimetastatic efficacy of oral 5-FU imaged by green fluorescent protein in real time. Wang JW; Yang M; Wang X; Sun FX; Li XM; Yagi S; Hoffman RM Anticancer Res; 2003; 23(1A):1-6. PubMed ID: 12680187 [TBL] [Abstract][Full Text] [Related]
13. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM Cancer Res; 2004 Mar; 64(5):1828-33. PubMed ID: 14996746 [TBL] [Abstract][Full Text] [Related]
14. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice. Hosotani R; Miyamoto Y; Fujimoto K; Doi R; Otaka A; Fujii N; Imamura M Clin Cancer Res; 2002 Apr; 8(4):1271-6. PubMed ID: 11948142 [TBL] [Abstract][Full Text] [Related]
15. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Bouvet M; Spernyak J; Katz MH; Mazurchuk RV; Takimoto S; Bernacki R; Rustum YM; Moossa AR; Hoffman RM Cancer Res; 2005 Nov; 65(21):9829-33. PubMed ID: 16267005 [TBL] [Abstract][Full Text] [Related]
16. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice. Yang BW; Liang Y; Xia JL; Sun HC; Wang L; Zhang JB; Tang ZY; Liu KD; Chen J; Xue Q; Chen J; Gao DM; Wu WZ Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1077-84. PubMed ID: 19047839 [TBL] [Abstract][Full Text] [Related]
17. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975 [TBL] [Abstract][Full Text] [Related]
18. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model. Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445 [TBL] [Abstract][Full Text] [Related]
19. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Fujisawa T; Joshi B; Nakajima A; Puri RK Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609 [TBL] [Abstract][Full Text] [Related]
20. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer. Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]